H.R. 679 · Where this bill is now
In committee
Introduced in the House, sent to the Committee on Energy and Commerce, Jan 23, 2025
119th Congress
1st SessionH. R. 679
1st SessionH. R. 679
A BILL
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
In the HouseNo vote yet
Sponsor: Rep. Diana Harshbarger (R-TN-1) · Introduced Jan 23, 2025 · Health · 1 version of the text
Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Jan 23, 2025: “Referred to the House Committee on Energy and Commerce.”